{"instruction":"What are the different nomenclature categories for the experimental compound N-[4-(3-pyridylethynyl)-2-thiazolyl]acetamide?","input":"","output":"**Chemical identifiers**:\n- CHEMBL381482 (ChEMBL数据库编号)\n- SCHEMBL4153643 (公共化学标识符)\n\n**Structural classification**:\n- 噻唑类衍生物\n- 吡啶乙炔基结构单元"}
{"instruction":"What are the different classification types associated with the investigational drug AR-12?","input":"","output":"**Chemical nomenclature**:\n- 2-Amino-N-(4-(5-(phenanthren-2-yl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)phenyl)acetamide (IUPAC名称)\n- C26H19F3N4O (分子式)\n\n**Development codes**:\n- OSU-03012 (俄亥俄州立大学代号)\n- PDK1 inhibitor AR-12 (作用机制标识)\n\n**Regulatory identifiers**:\n- 742112-33-0 (CAS登记号)\n- UNII-EX3O2Q61UV (FDA物质唯一标识)"}
{"instruction":"How is the chemical entity Benzoic acid 8-aza-bicyclo[3.2.1]oct-6-yl ester formally identified?","input":"","output":"**Official designations**:\n- CHEMBL84113 (ChEMBL标准编号)\n\n**Structural features**:\n- 苯甲酸酯衍生物\n- 8-氮杂双环[3.2.1]辛烷骨架\n- 酯官能团定位6位"}
{"instruction":"What are the patent-related identifiers for US10150740, Example 9?","input":"","output":"**Patent documentation**:\n- US10150740 (美国专利号)\n- Example 9 (实施例编号)\n\n**Chemical registries**:\n- SCHEMBL18425902 (专利化合物标识)\n- BDBM307513 (生物活性数据库编号)"}
{"instruction":"What are the development stages and codes for Genaconazole?","input":"","output":"**Research phases**:\n- SM-8668 (早期研发代号)\n- Sch-39304 (Schering-Plough公司编号)\n\n**Derivative series**:\n- SM-9164 (结构类似物)\n- Sch-42426/42427 (优化阶段衍生物)"}